Literature DB >> 7725978

Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41,468), a selective 5-HT2-receptor antagonist. 1982.

F de Clerck, J L David, P A Janssen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7725978     DOI: 10.1007/bf01986694

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


× No keyword cloud information.
  29 in total

1.  Proceedings: Time-dependent potentiation and inhibition by 5-hydroxytryptamine of platelet aggregation induced by ADP.

Authors:  F Michal; M Motamed
Journal:  Br J Pharmacol       Date:  1975-06       Impact factor: 8.739

2.  5-hydroxytryptamine antagonists.

Authors:  L GYERMEK
Journal:  Pharmacol Rev       Date:  1961-09       Impact factor: 25.468

3.  Proceedings: Refractoriness in blood platelets: effect of prior exposure to aggregating agents on subsequent aggregation responses.

Authors:  R J Evans; J L Gordon
Journal:  Br J Pharmacol       Date:  1974-05       Impact factor: 8.739

4.  Platelet response to six agglutinating agents: species similarities and differences.

Authors:  R G Mason; M S Read
Journal:  Exp Mol Pathol       Date:  1967-06       Impact factor: 3.362

5.  Effects of 5-hydroxytryptamine on platelet aggregation.

Authors:  H R Baumgartner; G V Born
Journal:  Nature       Date:  1968-04-13       Impact factor: 49.962

6.  A biphasic response of platelets to serotonin.

Authors:  J G White
Journal:  Scand J Haematol       Date:  1970

7.  D-receptor for serotonin on blood platelets.

Authors:  F Michal
Journal:  Nature       Date:  1969-03-29       Impact factor: 49.962

Review 8.  Pharmacological control of platelet and red blood cell function in the microcirculation.

Authors:  F De Clerck; J L David
Journal:  J Cardiovasc Pharmacol       Date:  1981 Nov-Dec       Impact factor: 3.105

9.  Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors.

Authors:  J E Leysen; F Awouters; L Kennis; P M Laduron; J Vandenberk; P A Janssen
Journal:  Life Sci       Date:  1981-03-02       Impact factor: 5.037

10.  The comparison between ADP-induced aggregation and noradrenaline plus 5-hydroxytryptamine induced aggregation.

Authors:  S Takano; T Suzuki
Journal:  Fukushima J Med Sci       Date:  1978-02
View more
  1 in total

1.  Improvement of antithrombotic activity of red ginseng extract by nanoencapsulation using chitosan and antithrombotic cross-linkers: polyglutamic acid and fucodian.

Authors:  Eun Suh Kim; Ji-Soo Lee; Hyeon Gyu Lee
Journal:  J Ginseng Res       Date:  2020-04-10       Impact factor: 6.060

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.